120 related articles for article (PubMed ID: 25859168)
1. Evaluation of Enoxaparin Dosing and Monitoring in Pediatric Patients at Children's Teaching Hospital.
McCormick EW; Parbuoni KA; Huynh D; Morgan JA
J Pediatr Pharmacol Ther; 2015; 20(1):33-6. PubMed ID: 25859168
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Initial Enoxaparin Dosing and Antifactor Xa Levels in Infants Admitted to the Neonatal Intensive Care Unit.
Nagy R; Hemmelgarn T; Deptola S; Hemmann B
Biomed Hub; 2024; 9(1):54-61. PubMed ID: 38616894
[TBL] [Abstract][Full Text] [Related]
3. An Evaluation of the Appropriateness of Initial Enoxaparin Dosing Among Pediatric Patients.
Altuwayjiri A; AlDarwish A; Alshuraim R
Cureus; 2023 Nov; 15(11):e48830. PubMed ID: 38106767
[TBL] [Abstract][Full Text] [Related]
4. Monitoring Enoxaparin with Antifactor Xa Levels in Obese Patients.
Lee YR; Vega JA; Duong HN; Ballew A
Pharmacotherapy; 2015 Nov; 35(11):1007-15. PubMed ID: 26598093
[TBL] [Abstract][Full Text] [Related]
5. Retrospective comparison of two enoxaparin dosing and monitoring protocols at a pediatric hospital.
Wolsey A; Wilcox RA; Olson JA; Boehme S; Anderson CR
Am J Health Syst Pharm; 2019 May; 76(11):815-819. PubMed ID: 31361813
[TBL] [Abstract][Full Text] [Related]
6. Enoxaparin and antifactor Xa levels in acute burn patients.
Lin H; Faraklas I; Cochran A; Saffle J
J Burn Care Res; 2011; 32(1):1-5. PubMed ID: 21124231
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Enoxaparin Dosing as a Risk Factor for Bleeding in Lung Transplant Recipients.
Sofjan AK; Iuppa JA; Bain KB; Deal EN; Witt CA; Hachem RR; Yusen RD
Ann Pharmacother; 2016 Oct; 50(10):824-31. PubMed ID: 27363845
[TBL] [Abstract][Full Text] [Related]
8. Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*.
Schloemer NJ; Abu-Sultaneh S; Hanson SJ; Yan K; Hoffmann RG; Punzalan RC; Havens PL
Pediatr Crit Care Med; 2014 Sep; 15(7):e294-9. PubMed ID: 24901803
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a Pediatric Enoxaparin Dosing Protocol and the Impact on Clinical Outcomes.
Wiltrout K; Lissick J; Raschka M; Nickel A; Watson D
J Pediatr Pharmacol Ther; 2020; 25(8):689-696. PubMed ID: 33214779
[TBL] [Abstract][Full Text] [Related]
10. Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients.
Lin H; Faraklas I; Saffle J; Cochran A
J Trauma; 2011 Dec; 71(6):1557-61. PubMed ID: 22027887
[TBL] [Abstract][Full Text] [Related]
11. IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children: Comparison of Dosing, Anticoagulation Quality, Efficacy, and Safety Outcomes.
Diab YA; Ramakrishnan K; Ferrell B; Chounoune R; Alfares FA; Endicott KM; Rooney S; Corcoran J; Zurakowski D; Berger JT; Shankar V; Nath DS
Pediatr Crit Care Med; 2017 May; 18(5):e207-e214. PubMed ID: 28296662
[TBL] [Abstract][Full Text] [Related]
12. Enoxaparin and antifactor Xa levels in pediatric acute burn patients.
Brown A; Faraklas I; Ghanem M; Cochran A
J Burn Care Res; 2013; 34(6):628-32. PubMed ID: 24043233
[TBL] [Abstract][Full Text] [Related]
13. Enoxaparin dosage adjustment in patients with severe renal failure: antifactor xa concentrations and safety.
Lachish T; Rudensky B; Slotki I; Zevin S
Pharmacotherapy; 2007 Oct; 27(10):1347-52. PubMed ID: 17896889
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and Pharmacokinetics of Treatment Dose Enoxaparin in Hospitalized Patients With Morbid Obesity.
Thompson-Moore NR; Wanat MA; Putney DR; Liebl PH; Chandler WL; Muntz JE
Clin Appl Thromb Hemost; 2015 Sep; 21(6):513-20. PubMed ID: 25601898
[TBL] [Abstract][Full Text] [Related]
15. Novel uses of insulin syringes to reduce dosing errors: a retrospective chart review of enoxaparin whole milligram dosing.
Bauman ME; Black KL; Bauman ML; Belletrutti M; Bajzar L; Massicotte MP
Thromb Res; 2009 Apr; 123(6):845-7. PubMed ID: 19038418
[TBL] [Abstract][Full Text] [Related]
16. Dosing and monitoring of enoxaparin therapy in children: experience in a tertiary care hospital.
Andrade-Campos MM; Montes-Limón AE; Fernandez-Mosteirin N; Salvador-Osuna C; Torres M; Lucia-Cuesta JF; Rubio-Felix D
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):194-8. PubMed ID: 23358201
[TBL] [Abstract][Full Text] [Related]
17. An assessment of published pediatric dosage guidelines for enoxaparin: a retrospective review.
Ho SH; Wu JK; Hamilton DP; Dix DB; Wadsworth LD
J Pediatr Hematol Oncol; 2004 Sep; 26(9):561-6. PubMed ID: 15342982
[TBL] [Abstract][Full Text] [Related]
18. Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients.
Fung LS; Klockau C
J Pediatr Pharmacol Ther; 2010 Apr; 15(2):119-25. PubMed ID: 22477802
[TBL] [Abstract][Full Text] [Related]
19. IV enoxaparin in pediatric and cardiac ICU patients.
Cies JJ; Santos L; Chopra A
Pediatr Crit Care Med; 2014 Feb; 15(2):e95-103. PubMed ID: 24335994
[TBL] [Abstract][Full Text] [Related]
20. Enoxaparin use in the neonatal intensive care unit: experience over 8 years.
Malowany JI; Knoppert DC; Chan AK; Pepelassis D; Lee DS
Pharmacotherapy; 2007 Sep; 27(9):1263-71. PubMed ID: 17723080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
